[Skip to Content]
[Skip to Content Landing]

The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response

Educational Objective
To understand to role of the Advisory Committee on Immunization Practices during COVID-19
1 Credit CME

More than 3.7 million infections and more than 140 000 deaths due to coronavirus disease 2019 (COVID-19) have occurred in the US in the past 6 months. As case counts continue to increase, robust vaccine development efforts unprecedented in scale and speed are being pursued. More than 130 COVID-19 vaccines are in preclinical development using a variety of established and new platforms, and 17 candidate vaccines are undergoing evaluation in clinical trials in the US, Europe, and China.1 The US government has invested in the development of 5 vaccines as part of Operation Warp Speed.2 On June 25, the Chinese government approved the first COVID-19 vaccine (Ad5-nCoV) for use in the military population.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Grace M. Lee, MD, MPH, Stanford University School of Medicine, 300 Pasteur Dr, H306-A, Stanford, CA 94305 (gmlee@stanfordchildrens.org).

Published Online: July 22, 2020. doi:10.1001/jama.2020.13167

Conflict of Interest Disclosures: Drs Lee, Bell, and Romero are members of the Advisory Committee on Immunization Practices. No other disclosures were reported.

References
1.
World Health Organization. Draft landscape of COVID-19 candidate vaccines. Accessed June 29, 2020. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
2.
O’Callaghan  KP , Blatz  AM , Offit  PA .  Developing a SARS-CoV-2 vaccine at warp speed.   JAMA. Published online July 6, 2020. doi:10.1001/jama.2020.12190PubMedGoogle Scholar
3.
Smith  JC , Snider  DE , Pickering  LK .  Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices.   Ann Intern Med. 2009;150(1):45-49. doi:10.7326/0003-4819-150-1-200901060-00009PubMedGoogle ScholarCrossref
4.
Lee  G , Carr  W .  Updated framework for development of evidence-based recommendations by the Advisory Committee on Immunization Practices.   MMWR Morb Mortal Wkly Rep. 2018;67(45):1271-1272. doi:10.15585/mmwr.mm6745a4PubMedGoogle ScholarCrossref
5.
Centers for Disease Control and Prevention. COVID-19 in racial and ethnic minority groups. Accessed June 28, 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html
6.
Yoo  BK , Kasajima  M , Phelps  CE , Fiscella  K , Bennett  NM , Szilagyi  PG .  Influenza vaccine supply and racial/ethnic disparities in vaccination among the elderly.   Am J Prev Med. 2011;40(1):1-10. doi:10.1016/j.amepre.2010.09.028PubMedGoogle ScholarCrossref
7.
Food and Drug Administration; Center for Biologics Evaluation and Research. Development and licensure of vaccines to prevent COVID-19. Accessed July 2, 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
8.
Schaffer DeRoo  S , Pudalov  NJ , Fu  LY .  Planning for a COVID-19 vaccination program.   JAMA. 2020;323(24):2458-2459. doi:10.1001/jama.2020.8711 PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 CME points in the American Board of Surgery’s (ABS) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close